Records containing: Prostatic Hyperplasia
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2016-03-18A Randomized, Open-Label, Crossover, Single-Dose Study to Compare Pharmacokinetic Properties and Safety After Administration of HCP1303 Capsule and Co-administration of HGP1201 Tablet, HIP1402 Capsule in Healthy Male Volunteers
-
CLINICAL_TRIALS study record update · 2015-12-17A Pivotal, Open-label Trial Assessing the Safety and Efficacy of the 0.5 mg Dutasteride and 0.4 mg Tamsulosin Combination Once Daily for Six Months in Patients With Benign Prostatic Hyperplasia
-
CLINICAL_TRIALS study record update · 2015-07-14Aqueduct Irrigation System Clinical Protocol: Medical Device Investigational Plan
-
CLINICAL_TRIALS study record update · 2015-06-03Investigating the Role of microRNAs in the Regulation of Gene Expression and Organ Remodeling During Lower Urinary Tract Dysfunction, Including Bladder Pain Syndrome/Interstitial Cystitis (BPS), and Overactive Bladder Syndrome (OAB)
-
CLINICAL_TRIALS study record update · 2014-09-19Effect of ALNA® (Tamsulosin) on the Primary Symptoms of BPH (Benign Prostatic Hyperplasia) Syndrome
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2014-09-19Observational Study in Patients With Functional BPH (Benign Prostatic Hyperplasia) Symptoms Who Switched From Phytotherapy to ALNA® (Tamsulosin)
-
CLINICAL_TRIALS study record update · 2014-09-19An Eleven-Week, Open-Label, Randomized, Multicenter, Parallel-Design, Placebo Lead-in Study of FLOMAX® Capsules, 0.4 mg Daily Versus HYTRIN® Capsules, 5 mg (With Titration) Daily in Patients With the Signs and Symptoms of Benign Prostatic Hyperplasia
-
CLINICAL_TRIALS study record update · 2014-09-19Secotex ®: Prescription Event Monitoring in Patients With Benign Prostatic Hyperplasia (BPH)
-
CLINICAL_TRIALS study record update · 2014-09-19The Impact of Alna® Ocas® on Nocturia in Patients With Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH)
-
CLINICAL_TRIALS study record update · 2014-09-19A Forty-Five Day, Open-label Study of the Symptomatic Relief Effects of FLOMAX® Capsules 0.4 mg Daily in Patients With the Signs and Symptoms of Benign Prostatic Hyperplasia
-
CLINICAL_TRIALS study record update · 2014-09-19MICTUS (Multicentre Investigation to Characterise the Effect of Tamsulosin on Urinary Symptoms): A Multicentre, Double-blind, Randomised, Parallel Group Study, Aimed at Characterising the Effect of Tamsulosin, an Uroselective α1- Receptor Blocking Agent, on the Urological Symptoms and Their Impact on General Health Status and Quality of Life in Outpatients Affected by Symptomatic Benign Prostatic Hyperplasia: Comparison With Finasteride.
-
CLINICAL_TRIALS study record update · 2014-09-19Evolution of Patients Suffering From Benign Prostatic Hyperplasia (BPH) Treated With Alpha-adrenergic Blockade (JOSEPHINE)
-
CLINICAL_TRIALS study record update · 2014-09-19Comorbidity and Comedication During Prescription of ALNA® (Tamsulosin) for Patients With BPH (Benign Prostatic Hyperplasia)
-
CLINICAL_TRIALS study record update · 2014-09-19ALNA® - AWB in Pre-treated Patients With BPS
-
CLINICAL_TRIALS study record update · 2014-09-19BLADDER (BPH, LUTS And Detrusor: Dual Effect Research) Study: A Multicentre, Double-blind, Randomised, Parallel Group, Placebo-controlled Study, Aimed at Characterising the Effect of Tamsulosin on Lower Urinary Tract Symptoms (LUTS) and Detrusor Motor Activity in Patients Affected by Benign Prostatic Hyperplasia (BPH) and Storage Urinary Symptoms
-
CLINICAL_TRIALS study record update · 2014-09-19Observational Study About the Use of Tamsulosin in Patients With Benign Prostatic Hyperplasia
-
CLINICAL_TRIALS study record update · 2014-09-19Secotex®: Prescription Event Monitoring in Patients With Benign Prostatic Hyperplasia (BPH)
-
CLINICAL_TRIALS study record update · 2014-09-18Impact of Bladder Underactivity on Treatment Outcomes of Laser Prostatectomy: Comparison Between Potassium-titanyl-phosphate Photoselective Vaporization of the Prostate (PVP) and Holmium Laser Enucleation of the Prostate (HoLEP)
-
CLINICAL_TRIALS study record update · 2014-09-17ClinicalTrials.gov study NCT02243085
-
CLINICAL_TRIALS study record update · 2014-09-16Does Postoperative Pyuria Influence Treatment Outcomes After Photoselective Vaporization of the Prostate (PVP)?: A Short-term Serial Follow-up Study
-
CLINICAL_TRIALS study record update · 2014-09-03Phase II, Randomized, Double-blind, Multi-centered Study of Polyphenon E in Men With High-grade Prostatic Intraepithelial Neoplasia (HGPIN) or Atypical Small Acinar Proliferation (ASAP)
-
CLINICAL_TRIALS study record update · 2014-08-20A Randomized, Double-blind, Parallel Group, Placebo Controlled, Multi Center Dose Ranging Study of Solifenacin Succinate in Combination With Tamsulosin Hydrochloride Compared With Solifenacin Succinate Monotherapy and Tamsulosin Hydrochloride Monotherapy in Males With Lower Urinary Tract Symptoms (LUTS) Associated With Benign Prostatic Hyperplasia (BPH)
-
CLINICAL_TRIALS study record update · 2014-07-28Drug Use Investigation for AVOLVE(BPH)
-
CLINICAL_TRIALS study record update · 2014-06-16Comparative Efficacy of DuodartTM Versus Watchful Waiting With Step-up Therapy to Tamsulosin in the Management of Treatment naïve Men With Symptomatic BPH
-
CLINICAL_TRIALS study record update · 2014-03-31Prostate Mechanical Imager (PMI) Clinical Bridging Study